5-(3,5-dimethyl-4-methoxyphenyl)-5-oxovaleric acid, 97.0%, 1g

1,4-Benzenedicarboxaldehyde, 2,5-dichloro-, 98%, 250mg

O-(2,3,4,5,6-Pentafluorobenzyl)hydroxylamine Hydrochloride [for Oxime Preparation]>98.0%(HPLC)(N)5g

2-Bromo-5-methylsulfanyl-pyrazine, 95.0%, 5g

4-Cyclopentylphenol, 95+%, 5g

5-BROMO-6-CHLORO-7-FLUOROINDOLINE-2,3-DIONE, 95%, 5g

tert-Butyl 1H-pyrrole-3-carboxylate, 98%, 500mg

1-Amino-2-bromo-4-hydroxyanthracene-9,10-dione, 95.0%, 25g

3,3-DIMETHYLINDOLINE, 95.0%, 5g

trans-1,2-Dichloroethylene (stabilized with MEHQ)>98.0%(GC)100g

2-Methyl-1-(piperazin-1-yl)propan-2-ol, 98%, 5g

(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol, 95.0%, 500g

Enantiomer of Sofosbuvir, 1mg